Xiaoran Long

发表

LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis

Jie Cheng, Q. Tian, Wenjing Wang, 2020, Annals of translational medicine.

Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase

Wenjing Wang, W. Di, L. Dai, 2020, Scientific Reports.

Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis

Hao Hu, Q. Tian, Wenjing Wang, 2019, Journal of Experimental & Clinical Cancer Research.

Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis

Hao Hu, Q. Tian, Wenjing Wang, 2019, Journal of experimental & clinical cancer research : CR.

Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study

Y. Hertzanu, Haibin Shi, Hao Hu, 2014, PloS one.

Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma

G. Zhuang, Qing Li, Qing Li, 2023, Cancer medicine.

APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis

L. W. Cheung, Mei-Chun Cai, G. Zhuang, 2023, British Journal of Cancer.

Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo

W. Di, L. Dai, Xiaoran Long, 2019, OncoTargets and therapy.

Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study

Xiao-qiang Tong, Y. Hertzanu, Haibin Shi, 2015, PloS one.